Mirae Asset Global ETFs Holdings
TLSI icon

Mirae Asset Global ETFs Holdings’s TriSalus Life Sciences TLSI Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.7K Buy
14,435
+300
+2% +$1.47K ﹤0.01% 2871
2025
Q4 		$98.7K Buy
14,135
+5,461
+63% +$30.6K ﹤0.01% 2685
2025
Q3 		$40.3K Sell
8,674
-31
-0.4% -$145 ﹤0.01% 2982
2025
Q2 		$47.4K Buy
+8,705
New +$46.7K ﹤0.01% 2892

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TLSI Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its TriSalus Life Sciences (TLSI) stake by 2.1% in Q1 2026, buying an estimated $1.47K and bringing the position to 14,435 shares worth $57.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2871.

Mirae Asset Global ETFs Holdings first reported a position in TLSI in Q2 2025 and has held it in 4 quarters since. The position peaked at $98.7K in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 14,435 shares of TriSalus Life Sciences worth $57.7K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 300 TriSalus Life Sciences shares in Q1 2026, an estimated $1.47K.
  • TriSalus Life Sciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2871 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Mirae Asset Global ETFs Holdings's TriSalus Life Sciences position peaked at $98.7K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.